First Light Asset Management »

Edgewise Therapeutics shares owned by First Light Asset Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by First Light Asset Management from 13F filings

Historical chart of First Light Asset Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by First Light Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $23M 1.4M 16.22
2025-06-30 $23M 1.7M 13.11
2025-03-31 $41M 1.9M 22.00
2024-12-31 $21M 781k 26.70

More positions owned by First Light Asset Management

Axogen Common Stocks (AXGN)
Performant Healthcare Common Stocks (PHLT)
Centessa Pharmaceuticals Common Stocks (CNTA)
Neogenomics Common Stocks (NEO)
Amylyx Pharmaceuticals Common Stocks (AMLX)
Crinetics Pharmaceuticals Common Stocks (CRNX)
Health Catalyst Common Stocks (HCAT)
Palvella Therapeutics Common Stocks (PVLA)
Twist Bioscience Corporation Common Stocks (TWST)
Lenz Therapeutics Common Stocks (LENZ)
Organogenesis Holdings Common Stocks (ORGO)
Atricure Common Stocks (ATRC)
Anaptys Bio Common Stocks (ANAB)
Si-bone Common Stocks (SIBN)
Cidara Therapeutics Common Stocks (CDTX)

View all positions for First Light Asset Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
Baker Bros. Advisors
BlackRock
Paradigm Biocapital Advisors
Novo A/S
Braidwell
Henderson Group
Vanguard Group
Cormorant Asset Management
Siren
Perceptive Advisors
Bellevue Group
Driehaus Capital Management
MPM Oncology Impact Management

View all funds holding Edgewise Therapeutics